Virginia Knight

424 total citations
15 papers, 313 citations indexed

About

Virginia Knight is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Virginia Knight has authored 15 papers receiving a total of 313 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hepatology, 10 papers in Epidemiology and 2 papers in Surgery. Recurrent topics in Virginia Knight's work include Liver Disease Diagnosis and Treatment (10 papers), Hepatocellular Carcinoma Treatment and Prognosis (7 papers) and Hepatitis B Virus Studies (4 papers). Virginia Knight is often cited by papers focused on Liver Disease Diagnosis and Treatment (10 papers), Hepatocellular Carcinoma Treatment and Prognosis (7 papers) and Hepatitis B Virus Studies (4 papers). Virginia Knight collaborates with scholars based in Australia. Virginia Knight's co-authors include William Sievert, Jorge Tchongue, Peter G. Tipping, Dinushka Lourensz, Sally Bell, Amanda Nicoll, Anouk Dev, Stuart K. Roberts, Paul Gow and Michael Fink and has published in prestigious journals such as Hepatology, Journal of Hepatology and Nutrients.

In The Last Decade

Virginia Knight

15 papers receiving 312 citations

Peers

Countries citing papers authored by Virginia Knight

Since Specialization

Citations

This map shows the geographic impact of Virginia Knight's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Virginia Knight with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Virginia Knight more than expected).

Fields of papers citing papers by Virginia Knight

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Virginia Knight. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Virginia Knight. The network helps show where Virginia Knight may publish in the future.

Co-authorship network of co-authors of Virginia Knight

This figure shows the co-authorship network connecting the top 25 collaborators of Virginia Knight. A scholar is included among the top collaborators of Virginia Knight based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Virginia Knight. Virginia Knight is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Very Delayed Acute Hepatitis after Pembrolizumab Therapy for Advanced Malignancy: How Long Should We Watch? 2021 ·Current Oncology ·Timothy S. Phan, (unknown), Lara Lipton, Virginia Knight, (unknown), Stephen Pianko	8
2	Surveillance improves survival of patients with hepatocellular carcinoma: a prospective population‐based study 2018 ·The Medical Journal of Australia ·(unknown), Paul Gow, Michael Fink, Anouk Dev, Stuart K. Roberts, Amanda Nicoll, John Lubel, Ian Kronborg, (unknown), Marno Ryan, William Kemp, Virginia Knight, Vijaya Sundararajan, Paul Desmond, (unknown), Sally Bell	43
3	Liver stiffness measurement in the primary care setting detects high rates of advanced fibrosis and predicts liver-related events in hepatitis C 2018 ·Journal of Hepatology ·(unknown), William Kemp, Amanda Nicoll, Stuart K. Roberts, Paul Gow, Anouk Dev, Sally Bell, Siddharth Sood, Ian Kronborg, Virginia Knight, (unknown), John Lubel	24
4	Treatment choice for early-stage hepatocellular carcinoma in real-world practice: impact of treatment stage migration to transarterial chemoembolization and treatment response on survival 2018 ·Scandinavian Journal of Gastroenterology ·Stuart K. Roberts, (unknown), John Lubel, Paul Gow, Sally Bell, Amanda Nicoll, Anouk Dev, Michael Fink, Siddharth Sood, Virginia Knight, (unknown), Eldho Paul, (unknown), Ammar Majeed, (unknown), (unknown)	14
5	Cytoplasmic domain of tissue factor promotes liver fibrosis in mice 2017 ·World Journal of Gastroenterology ·Virginia Knight, Dinushka Lourensz, Jorge Tchongue, (unknown), Peter G. Tipping, William Sievert	12
6	Coffee Intake Is Associated with a Lower Liver Stiffness in Patients with Non-Alcoholic Fatty Liver Disease, Hepatitis C, and Hepatitis B 2017 ·Nutrients ·Alexander Hodge, (unknown), (unknown), (unknown), Philip Marsh, Virginia Knight, William Sievert, Barbora de Courten	33
7	Impact of viral hepatitis aetiology on survival outcomes in hepatocellular carcinoma: A large multicentre cohort study 2017 ·Journal of Viral Hepatitis ·(unknown), (unknown), Paul Gow, Michael Fink, John Lubel, Amanda Nicoll, (unknown), (unknown), Marno Ryan, Virginia Knight, Anouk Dev, Siddharth Sood, Sally Bell, Eldho Paul, Stuart K. Roberts	13
8	Community Approach Targeting Cirrhosis and Hepatocellular Carcinoma – Catch 2016 ·Journal of Hepatology ·(unknown), William Kemp, Anouk Dev, (unknown), (unknown), Sally Bell, Ian Kronborg, Virginia Knight, (unknown), John Lubel	1
9	Sorafenib in the treatment of hepatocellular carcinoma: a multi-centre real-world study 2016 ·Scandinavian Journal of Gastroenterology ·Adam Doyle, Philip Marsh, (unknown), (unknown), (unknown), (unknown), (unknown), Simone I. Strasser, Sally Bell, Marno Ryan, Amanda Nicoll, John Lubel, Paul Gow, Michael Fink, Stuart K. Roberts, (unknown), Ian Kronborg, (unknown), Virginia Knight, Anouk Dev	9
10	Radiofrequency ablation versus resection for the treatment of early stage hepatocellular carcinoma: a multicenter Australian study 2015 ·Scandinavian Journal of Gastroenterology ·(unknown), Michael Fink, Sally Bell, Paul Gow, Amanda Nicoll, Virginia Knight, Anouk Dev, (unknown), Michael Bailey, Wa Cheung, William Kemp, Stuart K. Roberts	29
11	Novel population‐based study finding higher than reported hepatocellular carcinoma incidence suggests an updated approach is needed 2015 ·Hepatology ·(unknown), Paul Gow, Michael Fink, Anouk Dev, Stuart K. Roberts, Amanda Nicoll, John Lubel, Ian Kronborg, (unknown), Marno Ryan, William Kemp, Virginia Knight, Helen Farrugia, Vicky Thursfield, Paul Desmond, Alexander Thompson, Sally Bell	45
12	Epidemiology of hepatitis B‐associated hepatocellular carcinoma in Victoria 2012 ·Internal Medicine Journal ·Marie Sinclair, Stuart K. Roberts, William Kemp, Virginia Knight, Anouk Dev, Paul Gow, Hamish Philpott, Ian Kronborg, (unknown), Sally Bell, (unknown), Alexandra Gorelik, Amanda Nicoll	6
13	1004 RADIOFREQUENCY ABLATION VERSUS SURGICAL RESECTION FOR THE TREATMENT OF EARLY STAGE HEPATOCELLULAR CARCINOMA (HCC) - A LARGE MULTICENTRE STUDY 2012 ·Journal of Hepatology ·(unknown), (unknown), Stacie Bell, (unknown), Amanda Nicoll, Virginia Knight, Anouk Dev, (unknown), Matthew T. Kitson, Michael Bailey, William Kemp, (unknown)	2
14	Digital Research 2012 2012 ·(unknown), (unknown), Simon Price, David Boyd, Virginia Knight, (unknown), (unknown)	1
15	Protease-activated receptor 2 promotes experimental liver fibrosis in mice and activates human hepatic stellate cells 2011 ·Hepatology ·Virginia Knight, Jorge Tchongue, Dinushka Lourensz, Peter G. Tipping, William Sievert	73

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact